NEOGENOMICS INC — Director's Dealing 2013

Nov 20, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2013-02-21

Reporting Person: ALBITAR MAHER (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	34000	Indirect
Common Stock	15000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to buy)	$1.43	2017-01-09	Common Stock (250000)		Direct
Warrants (Right to Buy)	$1.43	2017-01-09	Common Stock (200000)		Direct

Footnotes

F1: These stock options were granted upon the start of Mr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company.

F2: These warrants were issued to Mr. Albitar upon the start of his service to the Company and vest upon the acheivement of certain currently unmet milestones.